Cipla Ltd logo

Cipla Ltd

NSE: CIPLA BSE: 500087

₹1338

+7.10 (0.53%)

Sat, 31 Oct 2026, 04:55 am

mtf coin illustrationMTF 5xInvest in Cipla Ltd with 5x LeverageBuy with MTFpremium button ring illustration
Market Cap (in Cr)108012.3
PE Ratio32.09
Dividend0.97
Health TechnologyHealth Technology
Pharmaceuticals: OtherPharmaceuticals: Other
24.5K24.5K

Cipla Share Price Live Chart

1 Day

+7.10 (0.53%)

No Result Found

Summary

  • Market Cap (in Cr)

    111486.14

  • Net Profit (in Cr)

    3869.79

  • P/B

    2.87

  • Sector P/E

    37.68

  • P/E

    25.47

  • EV/EBITDA

    15.12

  • Debt/Equity (Industry)

    0.19

  • Interest Cover (Industry)

    13.14

  • ROCE (Industry)

    12.29

  • RONW (Industry)

    10.69

  • ROE

    11.79

  • ROCE

    15.66

  • Debt/Equity

    0.02

  • EPS (TTM)

    38.44

  • Dividend Yield

    0.94

  • Book Value

    438.13

  • Interest Cover

    97.04

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Dividends paid are well covered by earnings (6.4x coverage).
  • Dividends after 3 years are expected to be well covered by earnings (6.2x coverage).
  • Dividends per share have been stable in the past 10 years.
  • Cipla's earnings growth is expected to exceed the low risk savings rate of 7.2%.
thumbs up icon

Cons

  • Cipla's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Cipla's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • Cash flow for Cipla is expected to decrease over the next 2 years.
  • Cipla's earnings are expected to grow by 17.6% yearly, however this is not considered high growth (20% yearly).
  • Cipla's earnings growth is positive but not above the India market average.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersSEPT 2026JUN 2026MAR 2026DEC 2025SEPT 2025
Promoters29.2129.2129.2129.2129.21
FII20.2520.2122.5523.9324.54
DII34.9434.6331.9730.7230.25
Public15.6115.9416.2616.1315.99
Government0.000.000.000.000.00

Read More

Technical Analysis

RSI

59.16

MACD

-2.09

50 DMA

1370.46

200 DMA

1364.50

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic1534.801453.401399.7013721318.301290.601209.20
Fibonacci1453.401422.311403.0913721340.911321.691290.60
Camarilla1368.381360.921353.4613721338.541331.081323.62

Pivots Level: Classic

R3

+162.80

1534.80

R2

+81.40

1453.40

R1

+27.70

1399.70

1372
1372
Pivot Point
LTP: 1378.90

S1

-53.70

1318.30

S2

-81.40

1290.60

S3

-162.80

1209.20

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    1350.78

  • 20-EMA

    1347.94

  • 30-EMA

    1353.47

  • 50-EMA

    1365.84

  • 100-EMA

    1379.37

  • 200-EMA

    1394.14

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
27 Oct 2026board-meetingsQuarterly Results
13 May 2026board-meetingsAccounts, Quarterly Results, Final Dividend
13 May 2026dividend₹13.00 Dividend /Share05 Jun 2026
13 May 2026agm
23 Jan 2026board-meetingsQuarterly Results
30 Oct 2025board-meetingsQuarterly Results
27 May 2025dividendFinal Dividend - Rs. - 1327 Jun 2025
13 May 2025agm
13 May 2025dividend₹13.00 Dividend /Share27 Jun 2025
02 Jul 2024dividendFinal Dividend - Rs. - 1302 Aug 2024

Read More

Peer Comparison

Cipla Ltd logo

Cipla Ltd

Laurus Labs Ltd logo

Laurus Labs Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Zydus Lifesciences Ltd logo

Zydus Lifesciences Ltd

Read More

Cipla Ltd About

Cipla a leading Indian multinational pharmaceutical and biotechnology company headquartered in Mumbai, Maharashtra.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1935

Headquarters

CEO

Y K Hamied

Employees

Contact

Website icon

Website

http://www.cipla.com

Email icon

Email

cosecretary@cipla.com, contactus@cipla.com

Phone icon

Phone

91-22-24826000

Location icon

Location

Cipla House Peninsula Buss Par, Ganpatrao Kadam Mg Lower Parel, Mumbai, Maharashtra, 400013

Read More

Cipla Ltd Company History

YearHistory
2020
  • Completed phase-3 clinical study of generic asthma drug.
  • Inked licensing pact with Gilead Sciences for potential COVID-19 treatment drug.
  • Launched generic remdesivir for coronavirus patients.
  • Collaborated with Stempeutics to launch Stempeucel for CLI treatment in India.
  • Launched antibody detection kit for COVID-19 in India.
  • Conferred Golden Peacock Global Award for Excellence in Corporate Governance 2020.
2021
  • Set up 30 MW solar plant in Maharashtra.
  • Partnered with Alvotech to market biosimilars in Australia and New Zealand.
  • Bagged National Energy Conservation Award 2021 in drug and pharmaceutical sector.
  • Won Gold for Remdesivir in Covid Care Brand Category.
2022
  • Launched leuprolide acetate injection depot (22.5mg).
  • Received USFDA approval for generic Revlimid (Lenalidomide Capsules).
  • Launched child-friendly 4-in-1 antiretroviral treatment for HIV with DNDi in South Africa.
  • Scored highest among pharma companies in CRISIL Sustainability Rating 2022.
  • Won Frost & Sullivan and TERI Sustainability 4.0 Award.
2023
  • Acquired additional stake in GoApptiv Private Limited.
  • Announced acquisition of South Africa-based Actor Pharma.
2024
  • Acquired additional shares in Achira Labs Private Limited.
  • Merged Cipla Technologies LLC, USA with Cipla USA Inc.
  • Announced joint venture in the US with Kemwell Biopharma and Manipal Education & Medical Group for cell therapy products.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
GOLDMAN SACHS (SINGAPORE) PTE.- ODIblockSell91604156516 Oct 2025
GOLDMAN SACHS BANK EUROPESE - ODIblockBuy91604156516 Oct 2025
THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ400045828blockSell156532148514 Jul 2025
THE MTBJ LTD.AS TRST FOR GOVERNMENT PENSION INVESTMENT FUND MTBJ400045849blockBuy156532148514 Jul 2025
SAMINA HAMIEDbulkSell89547501518.7502 Dec 2024
RUMANA HAMIEDbulkSell49432501518.7502 Dec 2024
SAMINA HAMIEDbulkSell8954750134515 May 2024
ICICI PRUDENTIAL MUTUAL FUNDbulkBuy5525999134515 May 2024
SHIRIN HAMIEDbulkSell6363000134515 May 2024
RUMANA HAMIEDbulkSell4943250134515 May 2024

Read More

Cipla Ltd News

Cipla targets $1 billion North America revenue by FY27

Cipla plans to reach $1 billion revenue in North America by FY27. The strategy focuses on growth through new product launches in the region.

27 Oct 2026

companies

Cipla appoints Rashmi Joshi as independent director

Cipla Limited has appointed Rashmi Joshi as an additional and independent director for a five-year term, effective October 27, 2026, subject to shareholder approval.

27 Oct 2026

companies

Cipla Q2 net profit falls 35% YoY

Cipla reported a 35% YoY decline in consolidated net profit to ₹8.8 billion. Revenue dipped to ₹74 billion, missing estimates, while EBITDA margin contracted sharply.

27 Oct 2026

companies

Cipla to host Q2FY27 earnings call on Oct 27

Cipla Limited will release Q2FY27 unaudited financial results on October 27, 2026. An earnings conference call is scheduled for 4:00 pm IST.

13 Oct 2026

companies

Maharashtra FDA cancels Cipla unit's drug sale licence

Maharashtra FDA has cancelled the drug sale licence of a Cipla unit over alleged violations, as reported by a newspaper. The development raises regulatory concerns for the pharma major.

03 Oct 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Cipla Ltd?

    As of 31/10/2026 at 10:25 AM, Cipla Ltd shares are trading at ₹1338.

  • 2.What is the market cap. of Cipla Ltd?

    As of 31/10/2026, the market capitalization of Cipla Ltd is ₹1,08,012.30 crore.

  • 3.When was Cipla Ltd founded?

    Cipla Ltd was founded in 1935.

  • 4.What are the P/E and P/B ratios of Cipla Ltd?

    As of 31/10/2026, Cipla Ltd has a P/E ratio of 32.09 and a P/B ratio of 2.87.

  • 5.How can I buy shares of Cipla Ltd?

    You can buy shares of Cipla Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Cipla Ltd?

    As of September,2026, promoters hold 29.21% in Cipla Ltd, while FIIs, DIIs and public shareholders hold 20.25%, 34.94% and 15.61%, respectively. The government holds 0.00%.

  • 7.Does Cipla Ltd pay dividends?

    Yes, Cipla Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹13.00 Dividend /Share per share.

  • 8.What is the dividend yield of Cipla Ltd?

    As of 31 October, 2026, the dividend yield of Cipla Ltd stands at 0.97%.

  • 9.What are the latest financial results of Cipla Ltd?

    For the financial year ended March 2025, Cipla Ltd reported revenue of ₹27,454.00 crore and a net profit of ₹5,273.00 crore.

  • 10.What is the Stock symbol of Cipla Ltd?

    CIPLA is the stock symbol of Cipla Ltd.

  • 11.Who is the CEO of Cipla Ltd?

    The CEO of Cipla Ltd is Y K Hamied.

pocketful logo lightpocketful logo dark
PricingBecome a Partner
search icon
/

No results for ''

Popular search

  • popular search iconSuzlon Energy Ltd
  • popular search iconIndian Railway Finance Corporation Ltd
  • popular search iconTata Motors Ltd
  • popular search iconTata Steel Ltd
  • popular search iconRail Vikas Nigam Ltd

Recent search

      Log In
      search icon

      No results for ‘’

        Popular search

        • popular search iconSuzlon Energy Ltd
        • popular search iconIndian Railway Finance Corporation Ltd
        • popular search iconTata Motors Ltd
        • popular search iconTata Steel Ltd
        • popular search iconRail Vikas Nigam Ltd
        • popular search iconReliance Industries Ltd
        pocketful logo lightpocketful logo dark
        • Pricing
        • Become a Partner
        Log In
        • home icon
        • arrow iconstocks
        • arrow iconcipla ltd
        • Overview
        • Analysis
        • Financials
        • Ratios
        • shareholding
        • Technical Analysis
        • Corporate Actions
        • Peer Comparison
        • About
        • Company History
        • Deals
        • News
        • FAQs

        Open Your Free Demat Account Now!

        Step into a world of zero fees and limitless opportunities!

        pocketful logo
        • Quick Links

          • Open Demat Account
          • Pocketful Web
          • Pocketful App
          • Pricing
          • Authorised Person
          • Pocketful Calculators
          • Compliance Links
        • Pages

          • Tools
          • Blogs
          • ETF Screener
          • IPO
          • ETF
          • Bonds
          • Index Heat Map
        • Products

          • Stocks
          • Commodity
          • Subscription
          • Free Stock Screener
          • Pocketful GPT
          • MTF
          • Mutual Funds
        • Company

          • About us
          • Contact us
          • Terms and Conditions
          • Policies & Procedures
          • Privacy Policy
          • Disclosure
          • Careers
        • Socials

          • Facebook iconFacebook
          • Twitter iconTwitter
          • Instagram iconInstagram
          • LinkedIn iconLinkedIn
          • Youtube iconYoutube

        2022-25 Pocketful. All rights reserved, Built with in India

        Version -5.76

        app image 1app image 2

        Stocks:

        AllABCDEFGHIJKLMNOPQRSTUVWXYZ

        Explore

        Calculators
        Popular Calculators
        Group Stocks
        Asset Management Companies
        Popular Stocks
        Indian Indices
        Sector Wise Stocks
        IPO
        Share Market
        Best MF Schemes
        Platforms
        Resources
        Gold Rates in Top Cities
        Silver Rates in Top Cities

        Others:

        NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

        Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800